Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate® ) and BAY 81-8973 (Kovaltry® ) in patients with severe or moderate haemophilia A in prophylaxis.

Megías-Vericat JE, Bonanad S, Haya S, Cid AR, Marqués MR, Monte-Boquet E, Pérez-Alenda S, Bosch P, Querol F, Poveda JL.

Haemophilia. 2019 Mar 13. doi: 10.1111/hae.13733. [Epub ahead of print] No abstract available.

PMID:
30866068
2.

Upper-Body Exercises With External Resistance Are Well Tolerated and Enhance Muscle Activity in People With Hemophilia.

Calatayud J, Pérez-Alenda S, Carrasco JJ, Escriche A, Cruz-Montecinos C, Andersen LL, Bonanad S, Querol F, Casaña J.

Phys Ther. 2019 Jan 23. doi: 10.1093/ptj/pzy136. [Epub ahead of print]

PMID:
30690577
3.

Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A.

Megías-Vericat JE, Bonanad S, Haya S, Cid AR, Marqués MR, Monte E, Pérez-Alenda S, Bosch P, Querol F, Poveda JL.

Thromb Res. 2019 Feb;174:151-162. doi: 10.1016/j.thromres.2018.12.027. Epub 2019 Jan 3.

PMID:
30634166
4.

Predictive factors of immune tolerance treatment response in severe haemophilia A patients with inhibitors: A real-world report from a single centre, mixed retrospective-prospective long-term study.

Haya S, Solano C, Cid AR, Argilés B, Hervás D, Querol F, Bonanad S, Casaña P.

Haemophilia. 2019 Mar;25(2):e97-e100. doi: 10.1111/hae.13660. Epub 2019 Jan 3. No abstract available.

PMID:
30604912
5.

Joint status in Spanish haemophilia B patients assessed using the Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score.

Jiménez-Yuste V, Álvarez-Román MT, Martín-Salces M, De la Corte-Rodríguez H, Altisent C, Parra R, Núñez R, Pérez R, García-Candel F, Bonanad S, Querol F, Alonso N, Fernández-Mosteirín N, López-Ansoar E, García-Frade LJ, Bermejo N, Pérez-González N, Gutiérrez-Pimentel MJ, Martinoli C, Fernández-Arias I, Kim HK.

Haemophilia. 2019 Jan;25(1):144-153. doi: 10.1111/hae.13628. Epub 2018 Nov 16.

PMID:
30444298
6.

Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA.

Borràs N, Orriols G, Batlle J, Pérez-Rodríguez A, Fidalgo T, Martinho P, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Parra R, Altisent C, Cid AR, Bonanad S, Cabrera N, Moret A, Mingot-Castellano ME, Navarro N, Pérez-Montes R, Marcellin S, Moreto A, Herrero S, Soto I, Fernández-Mosteirín N, Jiménez-Yuste V, Alonso N, de Andrés-Jacob A, Fontanes E, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Quismondo NC, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, Tenorio JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Dobón M, Aguilar C, Vidal F, Corrales I.

Haematologica. 2019 Mar;104(3):587-598. doi: 10.3324/haematol.2018.203166. Epub 2018 Oct 25.

7.

HemoKinect: A Microsoft Kinect V2 Based Exergaming Software to Supervise Physical Exercise of Patients with Hemophilia.

Mateo F, Soria-Olivas E, Carrasco JJ, Bonanad S, Querol F, Pérez-Alenda S.

Sensors (Basel). 2018 Jul 26;18(8). pii: E2439. doi: 10.3390/s18082439.

8.

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.

Pérez-Rodríguez A, Batlle J, Corrales I, Borràs N, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Navarro N, Altisent C, Pérez-Montes R, Marcellini S, Moreto A, Herrero S, Soto I, Fernández Mosteirín N, Jiménez-Yuste V, Alonso N, de Andrés Jacob A, Fontanes E, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Castro Quismondo N, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, Tenorio M, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Dobón M, Aguilar C, Batlle F, Vidal F, López-Fernández MF.

PLoS One. 2018 Jun 20;13(6):e0197876. doi: 10.1371/journal.pone.0197876. eCollection 2018.

9.

Pilot evaluation of home delivery programme in haemophilia.

Megías-Vericat JE, Monte-Boquet E, Martín-Cerezuela M, Cuéllar-Monreal MJ, Tarazona-Casany MV, Pérez-Huertas P, Bonanad S, Poveda-Andrés JL.

J Clin Pharm Ther. 2018 Dec;43(6):822-828. doi: 10.1111/jcpt.12718. Epub 2018 Jun 15.

PMID:
29906305
10.

Moderate and severe haemophilia in Spain: An epidemiological update.

Aznar JA, Altisent C, Álvarez-Román MT, Bonanad S, Mingot-Castellano ME, López MF.

Haemophilia. 2018 May;24(3):e136-e139. doi: 10.1111/hae.13462. Epub 2018 Mar 26. No abstract available.

PMID:
29578308
11.

Practice guidelines for the emergency treatment of thrombotic microangiopathy.

Romero S, Sempere A, Gómez-Seguí I, Román E, Moret A, Jannone R, Moreno I, Mendizábal S, Espí J, Peris A, Carbonell R, Cervera J, Pemán J, Bonanad S, de la Rubia J, Jarque I; Grupo de Microangiopatía Trombótica del Hospital Universitario y Politécnico La Fe de Valencia.

Med Clin (Barc). 2018 Aug 10;151(3):123.e1-123.e9. doi: 10.1016/j.medcli.2018.01.013. Epub 2018 Mar 11. English, Spanish.

PMID:
29534844
12.

α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism.

Martos L, Ramón LA, Oto J, Fernández-Pardo Á, Bonanad S, Cid AR, Gruber A, Griffin JH, España F, Navarro S, Medina P.

Thromb Haemost. 2018 Apr;118(4):630-638. doi: 10.1055/s-0038-1629902. Epub 2018 Feb 15.

13.

Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker.

Pérez-Alenda S, Carrasco JJ, Megías-Vericat JE, Poveda JL, Bonanad S, Querol F.

Haemophilia. 2018 Jan;24(1):e28-e32. doi: 10.1111/hae.13388. Epub 2017 Dec 22. No abstract available.

PMID:
29271553
14.

Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia.

Cid AR, Montesinos P, Sánchez-Guiu I, Haya S, Lorenzo JI, Sanz J, Moscardo F, Puig N, Planelles D, Bonanad S, Sanz GF, Vicente V, González-Manchón C, Lozano ML, Rivera J, Sanz MA.

Clin Case Rep. 2017 Oct 5;5(11):1887-1890. doi: 10.1002/ccr3.1206. eCollection 2017 Nov.

15.

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients.

Borràs N, Batlle J, Pérez-Rodríguez A, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Vidal F, Corrales I.

Haematologica. 2017 Dec;102(12):2005-2014. doi: 10.3324/haematol.2017.168765. Epub 2017 Sep 29.

16.

HaemoPREF: Further evaluation of patient perception and preference for treatment in a real world setting.

Bonanad S, Schulz M, Gordo A, Spurden D, Cicchetti M, Cappelleri JC, Tolley C, Staunton H, Brohan E.

Haemophilia. 2017 Nov;23(6):884-893. doi: 10.1111/hae.13321. Epub 2017 Sep 19.

PMID:
28925586
17.

Effect of radiosynoviorthesis on the progression of arthropathy and haemarthrosis reduction in haemophilic patients.

Querol-Giner M, Pérez-Alenda S, Aguilar-Rodríguez M, Carrasco JJ, Bonanad S, Querol F.

Haemophilia. 2017 Nov;23(6):e497-e503. doi: 10.1111/hae.13326. Epub 2017 Sep 11.

PMID:
28891593
18.

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.

Almeida AM, Prebet T, Itzykson R, Ramos F, Al-Ali H, Shammo J, Pinto R, Maurillo L, Wetzel J, Musto P, Van De Loosdrecht AA, Costa MJ, Esteves S, Burgstaller S, Stauder R, Autzinger EM, Lang A, Krippl P, Geissler D, Falantes JF, Pedro C, Bargay J, Deben G, Garrido A, Bonanad S, Diez-Campelo M, Thepot S, Ades L, Sperr WR, Valent P, Fenaux P, Sekeres MA, Greil R, Pleyer L.

Int J Mol Sci. 2017 Apr 14;18(4). pii: E837. doi: 10.3390/ijms18040837.

19.

Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).

Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Pedro C, Tormo M, Montoro J, Díez-Campelo M, Blanco ML, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu M, Ferrer A, Sanz GF, Florensa L.

Am J Hematol. 2017 Jul;92(7):614-621. doi: 10.1002/ajh.24732. Epub 2017 May 9.

20.

Further psychometric validation of the GAH scale: Responsiveness and effect size.

Cruz-Jentoft AJ, González B, de la Rubia J, Hernández Rivas JÁ, Soler JA, Fernández Lago C, Arnao M, Gironella M, Pérez Persona E, Zudaire MT, Olivier C, Altés A, García Guiñón A, Nomdedeu B, Arnan M, Ramírez Payer Á, Sánchez-Godoy P, Pajuelo N, Vilanova D, Monjil DF, Bonanad S; GAH Group.

J Geriatr Oncol. 2017 May;8(3):211-215. doi: 10.1016/j.jgo.2016.12.008. Epub 2016 Dec 22.

PMID:
28017687
21.

Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.

Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Ardanaz MT, Pedro C, Tormo M, Montoro J, Díez-Campelo M, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L.

Mod Pathol. 2016 Dec;29(12):1541-1551. doi: 10.1038/modpathol.2016.146. Epub 2016 Aug 26.

22.

Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

Arenillas L, Calvo X, Luño E, Senent L, Alonso E, Ramos F, Ardanaz MT, Pedro C, Tormo M, Marco V, Montoro J, Díez-Campelo M, Brunet S, Arrizabalaga B, Xicoy B, Andreu R, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L.

J Clin Oncol. 2016 Sep 20;34(27):3284-92. doi: 10.1200/JCO.2016.66.9705. Epub 2016 Jul 5.

PMID:
27382099
23.

A simplified assay for the quantification of circulating activated protein C.

Martos L, Bonanad S, Ramón LA, Cid AR, Bonet E, Corral J, Miralles M, España F, Navarro S, Medina P.

Clin Chim Acta. 2016 Aug 1;459:101-104. doi: 10.1016/j.cca.2016.05.025. Epub 2016 Jun 2.

PMID:
27262823
24.

[Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria].

Villegas A, Arrizabalaga B, Bonanad S, Colado E, Gaya A, González A, Jarque I, Núñez R, Ojeda E, Orfao A, Ribera JM, Vicente V, Urbano-Ispizua Á; Grupo de Trabajo de HPN de la Sociedad Española de Hematología y Hemoterapia.

Med Clin (Barc). 2016 Mar 18;146(6):278.e1-7. doi: 10.1016/j.medcli.2015.12.012. Epub 2016 Feb 17. Spanish.

PMID:
26895645
25.

Platelet function in malignant hematological disorders.

Moscardó A, Latorre A, Santos MT, Bonanad S, Vallés J.

Curr Opin Oncol. 2015 Nov;27(6):522-31. doi: 10.1097/CCO.0000000000000237. Review.

PMID:
26447878
26.

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm.

Batlle J, Pérez-Rodríguez A, Corrales I, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Toll T, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto Mdel M, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Borràs N, Vidal F.

Thromb Haemost. 2016 Jan;115(1):40-50. doi: 10.1160/TH15-04-0282. Epub 2015 Aug 6.

PMID:
26245874
27.

Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale.

Bonanad S, De la Rubia J, Gironella M, Pérez Persona E, González B, Fernández Lago C, Arnan M, Zudaire M, Hernández Rivas JA, Soler A, Marrero C, Olivier C, Altés A, Valcárcel D, Hernández MT, Oiartzabal I, Fernández Ordoño R, Arnao M, Esquerra A, Sarrá J, González-Barca E, González J, Calvo X, Nomdedeu M, García Guiñón A, Ramírez Payer A, Casado A, López S, Durán M, Marcos M, Cruz-Jentoft AJ; GAH Group.

J Geriatr Oncol. 2015 Sep;6(5):353-61. doi: 10.1016/j.jgo.2015.03.003. Epub 2015 Jun 29.

PMID:
26139300
28.

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.

García-Dasí M, Aznar JA, Jiménez-Yuste V, Altisent C, Bonanad S, Mingot E, Lucía F, Giménez F, López MF, Marco P, Pérez R, Fernández MÁ, Paloma MJ, Galmes B, Herrero S, García-Talavera JA.

Haemophilia. 2015 Jul;21(4):458-64. doi: 10.1111/hae.12618. Epub 2015 Feb 4.

PMID:
25649244
29.

Home-delivered ultrasound monitoring for home treatment of haemarthrosis in haemophilia A.

Aznar JA, Pérez-Alenda S, Jaca M, García-Dasí M, Vila C, Moret A, Querol F, Bonanad S.

Haemophilia. 2015 Mar;21(2):e147-50. doi: 10.1111/hae.12622. Epub 2015 Jan 27. No abstract available.

PMID:
25623041
30.

Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score.

Falantes J, Delgado RG, Calderón-Cabrera C, Márquez-Malaver FJ, Valcarcel D, de Miguel D, Bailén A, Bargay J, Bernal T, González-Porras JR, Tormo M, Ramos F, Andreu R, Xicoy B, Nomdedeu B, Brunet S, Sánchez J, Jurado AF, Bonanad S, Pérez-Simón JA, Sanz G; Spanish Group of Myelodysplastic Syndromes (GESMD).

Leuk Res. 2015 Jan;39(1):52-7. doi: 10.1016/j.leukres.2014.10.004. Epub 2014 Oct 30.

PMID:
25487012
31.

Quality of thawed plasma inactivated with methylene blue after 48-hour storage.

Balaguer A, Moret A, Solves P, Bonanad S, Carpio N, Sanz MÁ.

Transfus Apher Sci. 2015 Feb;52(1):141-2. doi: 10.1016/j.transci.2014.11.005. Epub 2014 Nov 13. No abstract available.

PMID:
25440913
32.

Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development.

Mannucci PM, Shi Q, Bonanad S, Klamroth R.

Haemophilia. 2014 Sep;20 Suppl 6:2-16. doi: 10.1111/hae.12465. Review. Erratum in: Haemophilia. 2014 Sep;20(5):e376.

PMID:
24975700
33.

Inhibitor development after switching of FVIII concentrate in multitransfused patients with severe haemophilia A.

Aznar JA, Moret A, Ibáñez F, Vila C, Cabrera N, Mesa E, Bonanad S.

Haemophilia. 2014 Sep;20(5):624-9. doi: 10.1111/hae.12439. Epub 2014 Apr 3.

PMID:
24697977
34.

The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome.

Cordoba I, Gonzalez-Porras JR, Such E, Nomdedeu B, Luño E, de Paz R, Carbonell F, Vallespi T, Ardanaz M, Ramos F, Marco V, Bonanad S, Sanchez-Barba M, Costa D, Bernal T, Sanz GF, Cañizo MC.

Leuk Res. 2012 Mar;36(3):287-92. doi: 10.1016/j.leukres.2011.10.025. Epub 2011 Nov 30.

PMID:
22133642
35.

Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass.

Muedra V, Bonanad S, Gómez M, Villalonga V, Sánchez F, Llopis JE.

Perfusion. 2011 Nov;26(6):487-95. doi: 10.1177/0267659111412999. Epub 2011 Jun 10.

PMID:
21665912
36.

Cytogenetic risk stratification in chronic myelomonocytic leukemia.

Such E, Cervera J, Costa D, Solé F, Vallespí T, Luño E, Collado R, Calasanz MJ, Hernández-Rivas JM, Cigudosa JC, Nomdedeu B, Mallo M, Carbonell F, Bueno J, Ardanaz MT, Ramos F, Tormo M, Sancho-Tello R, del Cañizo C, Gómez V, Marco V, Xicoy B, Bonanad S, Pedro C, Bernal T, Sanz GF.

Haematologica. 2011 Mar;96(3):375-83. doi: 10.3324/haematol.2010.030957. Epub 2010 Nov 25.

37.

Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.

Aznar JA, Bonanad S, Montoro JM, Hurtado C, Cid AR, Soler MA, De Miguel A.

Vox Sang. 2000;79(3):156-60.

PMID:
11111234
38.

Clotting factors in cryoprecipitate and cryo-supernatant prepared from MB-treated fresh plasma.

Aznar JA, Montoro JM, Cid AR, Bonanad S, Hurtado C, Soler MA, De Miguel A.

Transfusion. 2000 Apr;40(4):493. No abstract available.

PMID:
10773066
39.

Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).

Hurtado C, Bonanad S, Soler Mf, Mirabet V, Blasco I, Planelles Mf, De Miguel A.

Haematologica. 2000 Apr;85(4):390-5.

40.

[Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].

Hurtado C, Bonanad S, Soler MA, Mirabet V, Blasco I, Planelles MD, de Miguel A.

Sangre (Barc). 1999 Oct;44(5):319-26. Spanish.

PMID:
10618907
41.

A new method for phenotyping red blood cells using microplates.

Llopis F, Carbonell-Uberos F, Montero MC, Bonanad S, Planelles MD, Plasencia I, Riol C, Planells T, Carrillo C, De Miguel A.

Vox Sang. 1999;77(3):143-8.

PMID:
10545850
42.

Prolonged molecular remission after PML/RAR alpha-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: is relevant pretransplant minimal residual disease in the graft?

Sanz MA, de la Rubia J, Bonanad S, Barragán E, Sempere A, Martín G, Martínez JA, Jiménez C, Cervera J, Bolufer P, Sanz GF.

Leukemia. 1998 Jun;12(6):992-5.

PMID:
9639431
43.
44.

HLA-DQA, -DQB and -DRB allele contribution to narcolepsy susceptibility.

Planelles D, Puig N, Beneto A, Gomez E, Rubio P, Mirabet V, Bonanad S, Blasco I, Montoro JA.

Eur J Immunogenet. 1997 Dec;24(6):409-21.

PMID:
9534039
45.

[Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].

López Guerrero JA, Bolufer P, Barragán E, Sanz Alonso M, Palau J, Sempere A, De la Rubia J, Bonanad S, Torregrosa MD.

Sangre (Barc). 1996 Dec;41(6):441-6. Spanish.

PMID:
9148421
46.

Cytokines and platelet activation in stored pooled buffy-coat-derived platelet concentrates: the issue of transfusional reactions.

Bonanad S, Soler MA, Mirabet V, Carbonell-Uberos F, Blasco I, Planelles MD, Hurtado C.

Br J Haematol. 1996 Dec;95(4):755-6. No abstract available.

PMID:
8982058
47.

Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.

de la Rubia J, Sanz GF, Martín G, Sempere A, Picón I, Carral A, Larrea L, Martínez J, Soler MA, Bonanad S, López F, Jarque I, Sanz MA.

Bone Marrow Transplant. 1996 Dec;18(6):1167-73.

PMID:
8971390
48.

[Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].

Barragán E, Bonanad S, López JA, Martín G, Martínez J, Sanz GF, Gomis F, Pérez ML, Senent ML, Larrea L, Bolufer P, Sanz MA.

Sangre (Barc). 1996 Jun;41(3):189-94. Spanish.

PMID:
8755206
49.

[Immunohematologic study in 112 patients with myelodysplastic syndromes: 10-year analysis].

Arriaga F, Bonanad S, Larrea L, de la Rubia J, López F, Sanz MA, Sanz G, Marty ML.

Sangre (Barc). 1995 Jun;40(3):177-80. Review. Spanish.

PMID:
7570268
50.

Carboplatin and etoposide in acute myeloid leukemia.

Sanz MA, Bonanad S, Sanz GF, Martín G.

Leukemia. 1994 Sep;8(9):1599-600. No abstract available.

PMID:
8090041

Supplemental Content

Loading ...
Support Center